Improving the production of carbamoyltobramycin by an industrial Streptoalloteichus tenebrarius through metabolic engineering
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13141-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Yun Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzho…. Hauptthemen laut MEDLINE: Metabolic Engineering, Actinomycetales, Actinobacteria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program.
Abstract (Originalsprache)
Tobramycin is an essential and extensively used broad-spectrum aminoglycoside antibiotic obtained through alkaline hydrolysis of carbamoyltobramycin, one of the fermentation products of Streptoalloteichus tenebrarius . To simplify the composition of fermentation products from industrial strain, the main byproduct apramycin was blocked by gene disruption and constructed a mutant mainly producing carbamoyltobramycin. The generation of antibiotics is significantly affected by the secondary metabolism of actinomycetes which could be controlled by modifying the pathway-specific regulatory proteins within the cluster. Within the tobramycin biosynthesis cluster, a transcriptional regulatory factor TobR belonging to the Lrp/AsnC family was identified. Based on the sequence and structural characteristics, tobR might encode a pathway-specific transcriptional regulatory factor during biosynthesis. Knockout and overexpression strains of tobR were constructed to investigate its role in carbamoyltobramycin production. Results showed that knockout of TobR increased carbamoyltobramycin biosynthesis by 22.35%, whereas its overexpression decreased carbamoyltobramycin production by 10.23%. In vitro electrophoretic mobility shift assay (EMSA) experiments confirmed that TobR interacts with DNA at the adjacent tobO promoter position. Strains overexpressing tobO with ermEp* promoter exhibited 36.36% increase, and tobO with kasOp* promoter exhibited 22.84% increase in carbamoyltobramycin titer. When the overexpressing of tobO and the knockout of tobR were combined, the production of carbamoyltobramycin was further enhanced. In the shake-flask fermentation, the titer reached 3.76 g/L, which was 42 . 42% higher than that of starting strain. Understanding the role of Lrp/AsnC family transcription regulators would be useful for other antibiotic biosynthesis in other actinomycetes. Key points • The transcriptional regulator TobR belonging to the Lrp/AsnC family was identified . • An oxygenase TobO was identified within the tobramycin biosynthesis cluster . • TobO and TobR have significant effects on the synthesis of carbamoyltobramycin .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China.
- Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311200, China.
- Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China. yuhaoran@zju.edu.cn.
- Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311200, China. yuhaoran@zju.edu.cn.
- Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China. linjp@zju.edu.cn.
Förderung
- National Key Research and Development Program
Zitieren
APA
Feng, Y., Jiang, Y., Chen, X., Zhu, L., Xue, H., Wu, M., Yang, L., Yu, H., & Lin, J. (2024). Improving the production of carbamoyltobramycin by an industrial Streptoalloteichus tenebrarius through metabolic engineering. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13141-2
Vancouver
Feng Y, Jiang Y, Chen X, Zhu L, Xue H, Wu M, et al. Improving the production of carbamoyltobramycin by an industrial Streptoalloteichus tenebrarius through metabolic engineering. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13141-2
BibTeX
@article{Feng2024,
author = {Feng, Yun and Jiang, Yiqi and Chen, Xutong and Zhu, Li and Xue, Hailong and Wu, Mianbin and Yang, Lirong and Yu, Haoran and Lin, Jianping},
title = {Improving the production of carbamoyltobramycin by an industrial Streptoalloteichus tenebrarius through metabolic engineering},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13141-2}
}
EUVIMED